FIELD: medicine.
SUBSTANCE: clinical and X-ray examinations of a patient suffering inflammatory pulmonary infiltrate are followed by the lipid release leukocyte ability (LRLA) analysis. If the LRLA values is less than or equal to 0.119 mmole/l, infiltrative pulmonary tuberculosis is diagnosed, while the values more than 0.119 mmole/l - pneumonia.
EFFECT: use of the declared technique enables well-timed differential diagnostics of infiltrative pulmonary tuberculosis and pneumonia, well-timed etiological therapy and reduced time of staying in hospital.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ASSESSING THE PROBABILITY OF THE PRESENCE OF PULMONARY TUBERCULOSIS IN THE GENERAL MEDICAL NETWORK IN PATIENTS WITH A PRELIMINARY DIAGNOSIS OF COMMUNITY-ACQUIRED PNEUMONIA | 2022 |
|
RU2799137C1 |
| METHOD FOR DIAGNOSING DISSEMINATED PULMONARY TUBERCULOSIS IN PATIENTS WITH HIV INFECTION AND NEGATIVE RESULTS OF BACTERIOSCOPIC AND IMMUNOLOGICAL METHODS | 2020 |
|
RU2750525C1 |
| METHOD FOR PREDICTING EXUDATIVE PLEURISY OF TUBERCULOUS ETIOLOGY | 2007 |
|
RU2321864C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF INFILTRATIVE PULMONARY TUBERCULOSIS AND CHRONIC BACTERIAL PNEUMONIA | 2004 |
|
RU2252703C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING PULMONARY TUBERCULOSIS | 1998 |
|
RU2143223C1 |
| 0 |
|
SU1783425A1 | |
| METHOD OF EXAMINATION AND ASSESSMENT OF CLINICAL EFFECTIVENESS IN PATIENTS WITH PULMONARY DISEASES | 2020 |
|
RU2739413C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CASEOUS PNEUMONIA | 2011 |
|
RU2462194C1 |
| METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS COMBINED WITH DIABETES MELLITUS | 2023 |
|
RU2825182C1 |
| METHOD OF DIAGNOSING TUBERCULOSIS | 2022 |
|
RU2802672C1 |
